TY - JOUR
TI - Tafamidis and tafamidis meglumine for amyloid cardiomyopathy
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2021
ET - 2021/06/24
VL - 44
IS - 4
DO - 10.18773/austprescr.2021.032
LA - eng
UR - https://australianprescriber.tg.org.au/articles/tafamidis-and-tafamidis-meglumine-for-amyloid-cardiomyopathy.html
KW - amyloid cardiomyopathy
KW - amyloidosis
KW - tafamidis
KW - tafamidis meglumine
KW - Vyndamax
KW - Vyndaqel
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -